ASX - By Stock
|
RHY |
Re:
Ann: Trading Halt
|
|
SteadyEddie
|
29 |
9.3K |
4 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
29
|
9.3K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Becoming a substantial holder
|
|
SteadyEddie
|
7 |
2.6K |
2 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
7
|
2.6K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Placement and Entitlement Offer
|
|
SteadyEddie
|
101 |
33K |
9 |
16/09/23 |
16/09/23 |
ASX - By Stock
|
101
|
33K
|
9
|
|
ASX - By Stock
|
HMD |
Re:
[INTERVIEW] HeraMED (ASX:HMD) taps investors for $2.58m via private placement
|
|
SteadyEddie
|
1 |
349 |
1 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
1
|
349
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Update to TGA Submission
|
|
SteadyEddie
|
198 |
73K |
0 |
07/03/23 |
07/03/23 |
ASX - By Stock
|
198
|
73K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Suspension from Official Quotation
|
|
SteadyEddie
|
69 |
23K |
2 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
69
|
23K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Approval to Start Phase I/II Diabetic Foot Ulcer Study
|
|
SteadyEddie
|
8 |
3.6K |
4 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
8
|
3.6K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: RHY 2022 AGM Presentation
|
|
SteadyEddie
|
21 |
7.1K |
3 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
21
|
7.1K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: RHY 2022 AGM Presentation
|
|
SteadyEddie
|
21 |
7.1K |
31 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
21
|
7.1K
|
31
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results of Scheme Meeting
|
|
SteadyEddie
|
250 |
79K |
9 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
250
|
79K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Terrible Tadpole just sold half his shares
|
|
SteadyEddie
|
66 |
17K |
11 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
66
|
17K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
SteadyEddie
|
446 |
97K |
2 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
446
|
97K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Computershare Calling - Pfizer feedback
|
|
SteadyEddie
|
96 |
33K |
13 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
96
|
33K
|
13
|
|
ASX - By Stock
|
RAP |
Computershare Calling - Pfizer feedback
|
|
SteadyEddie
|
96 |
33K |
26 |
09/07/22 |
09/07/22 |
ASX - By Stock
|
96
|
33K
|
26
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
SteadyEddie
|
425 |
123K |
18 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
123K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
SteadyEddie
|
118 |
37K |
27 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
118
|
37K
|
27
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension Extension
|
|
SteadyEddie
|
88 |
40K |
16 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
88
|
40K
|
16
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
SteadyEddie
|
1.0K |
291K |
3 |
19/03/22 |
19/03/22 |
ASX - By Stock
|
1.0K
|
291K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
SteadyEddie
|
1.0K |
291K |
6 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
1.0K
|
291K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
SteadyEddie
|
1.0K |
291K |
15 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
1.0K
|
291K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
SteadyEddie
|
1.0K |
291K |
21 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
1.0K
|
291K
|
21
|
|
ASX - By Stock
|
RAP |
Re:
Q2 closest to pin
|
|
SteadyEddie
|
27 |
7.9K |
9 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
27
|
7.9K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
ResApp could be the future of COVID-19 screening
|
|
SteadyEddie
|
181 |
59K |
16 |
12/09/21 |
12/09/21 |
ASX - By Stock
|
181
|
59K
|
16
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
SteadyEddie
|
130 |
45K |
21 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
130
|
45K
|
21
|
|
ASX - By Stock
|
RAP |
Re:
AI4COVID-19 - Preliminary diagnosis from cough samples
|
|
SteadyEddie
|
12 |
5.7K |
0 |
11/10/20 |
11/10/20 |
ASX - By Stock
|
12
|
5.7K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study
|
|
SteadyEddie
|
623 |
253K |
10 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
623
|
253K
|
10
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study
|
|
SteadyEddie
|
623 |
253K |
38 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
623
|
253K
|
38
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to Present at ********* Investor Webinar
|
|
SteadyEddie
|
145 |
42K |
3 |
20/07/20 |
20/07/20 |
ASX - By Stock
|
145
|
42K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Change of Director's Interest Notice
|
|
SteadyEddie
|
204 |
54K |
38 |
18/07/20 |
18/07/20 |
ASX - By Stock
|
204
|
54K
|
38
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to Present at ********* Investor Webinar
|
|
SteadyEddie
|
145 |
42K |
29 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
145
|
42K
|
29
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Coviu and ResApp Health Sign Service Agreement
|
|
SteadyEddie
|
405 |
112K |
11 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
405
|
112K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to Present at TechKnow Invest Roadshow Webinar
|
|
SteadyEddie
|
58 |
21K |
4 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
58
|
21K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Hardware and Wearable Devices to Expand ResApp's Markets
|
|
SteadyEddie
|
317 |
117K |
5 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
317
|
117K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Board Refresh
|
|
SteadyEddie
|
376 |
135K |
5 |
30/03/20 |
30/03/20 |
ASX - By Stock
|
376
|
135K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp Joins Startup Creasphere Digital Health Program
|
|
SteadyEddie
|
477 |
268K |
7 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
477
|
268K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
2020 The Year Of RAP
|
|
SteadyEddie
|
1.3K |
1.2M |
2 |
18/01/20 |
18/01/20 |
ASX - By Stock
|
1.3K
|
1.2M
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp Grants Option to Consumer Health Division of Sanofi
|
|
SteadyEddie
|
264 |
161K |
81 |
17/11/19 |
17/11/19 |
ASX - By Stock
|
264
|
161K
|
81
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 11 Nov
|
|
SteadyEddie
|
61 |
30K |
3 |
11/11/19 |
11/11/19 |
ASX - Short Term Trading
|
61
|
30K
|
3
|
|
ASX - Short Term Trading
|
|
Re:
Bullcharts vs Insight Trader vs anything else?
|
|
SteadyEddie
|
2 |
6.8K |
0 |
10/11/19 |
10/11/19 |
ASX - Short Term Trading
|
2
|
6.8K
|
0
|
|
ASX - Short Term Trading
|
|
Bullcharts vs Insight Trader vs anything else?
|
|
SteadyEddie
|
2 |
6.8K |
2 |
05/11/19 |
05/11/19 |
ASX - Short Term Trading
|
2
|
6.8K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
SteadyEddie
|
4.6K |
2.1M |
7 |
21/10/19 |
21/10/19 |
ASX - By Stock
|
4.6K
|
2.1M
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: At-Home Obstructive Sleep Apnoea Study Update
|
|
SteadyEddie
|
217 |
93K |
14 |
28/09/19 |
28/09/19 |
ASX - By Stock
|
217
|
93K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResAppDx-EU for Adult Respiratory Disease Receives CE Mark
|
|
SteadyEddie
|
140 |
73K |
61 |
26/09/19 |
26/09/19 |
ASX - By Stock
|
140
|
73K
|
61
|
|
ASX - By Stock
|
RAP |
Re:
Tony on Tv
|
|
SteadyEddie
|
92 |
29K |
2 |
06/06/19 |
06/06/19 |
ASX - By Stock
|
92
|
29K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Hardware and Wearable Devices to Expand ResApp's Markets
|
|
SteadyEddie
|
317 |
117K |
18 |
01/06/19 |
01/06/19 |
ASX - By Stock
|
317
|
117K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results from Australian Adult Clinical Study
|
|
SteadyEddie
|
324 |
166K |
36 |
23/04/19 |
23/04/19 |
ASX - By Stock
|
324
|
166K
|
36
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Change of Director's Interest Notice
|
|
SteadyEddie
|
92 |
27K |
0 |
05/12/18 |
05/12/18 |
ASX - By Stock
|
92
|
27K
|
0
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Alcidion signs major contract with Queensland Health
|
|
SteadyEddie
|
50 |
21K |
5 |
26/11/18 |
26/11/18 |
ASX - By Stock
|
50
|
21K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results of Annual General Meeting
|
|
SteadyEddie
|
66 |
37K |
10 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
66
|
37K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results of Annual General Meeting
|
|
SteadyEddie
|
66 |
37K |
97 |
15/11/18 |
15/11/18 |
ASX - By Stock
|
66
|
37K
|
97
|
|